Publications

Detailed Information

Increasing Incidence of Hepatitis A in Korean Adults

DC Field Value Language
dc.contributor.authorKim, Yoon Jun-
dc.contributor.authorLee, Hyo-Suk-
dc.date.accessioned2012-05-29T07:13:38Z-
dc.date.available2012-05-29T07:13:38Z-
dc.date.issued2010-
dc.identifier.citationINTERVIROLOGY; Vol.53 1; 10-14ko_KR
dc.identifier.issn0300-5526-
dc.identifier.urihttps://hdl.handle.net/10371/76563-
dc.description.abstractHepatitis A infection is caused by the hepatitis A virus (HAV), which is transmitted through the fecal-oral route. Lifelong protective antibodies are present after infection. The number of cases of adult hepatitis A has progressively been increasing during the last several decades in Korea. In addition, the pattern of age-specific seroprevalence of anti-HAV has changed with economic growth. The prevalence of anti-HAV in the 10-50-year age range has declined rapidly during the last 3 decades. As a result, this age group has a high risk for HAV infection and clinically overt hepatitis A is increasing in adolescents and adults. It is well established that the severity of the disease is related to the age of the patients. The development of more cases of adult hepatitis A with severe presentation is expected in the near future. The clinical features and the epidemiological shift of HAV underscore the importance in Korea, as well as in other countries with similar issues, of childhood vaccination and consideration of catch-up vaccination for adolescents and adults as well as of targeted vaccination for individuals at increased risk for infection or its complications. There is a need to extensively evaluate the nationwide epidemiology of HAV infection, make cost-benefit analyses of HAV vaccination, and establish guidelines for HAV vaccination. Copyright (C) 2010 S. Karger AG, Baselko_KR
dc.language.isoenko_KR
dc.publisherKARGERko_KR
dc.subjectEpidemiologyko_KR
dc.subjectVaccinationko_KR
dc.subjectKoreako_KR
dc.subjectHepatitis A, acuteko_KR
dc.subjectHepatitis A virusko_KR
dc.titleIncreasing Incidence of Hepatitis A in Korean Adultsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김윤준-
dc.contributor.AlternativeAuthor이효석-
dc.identifier.doi10.1159/000252778-
dc.citation.journaltitleINTERVIROLOGY-
dc.description.citedreferenceLee D, 2008, INTERVIROLOGY, V51, P70, DOI 10.1159/000127428-
dc.description.citedreferenceKang CI, 2007, J KOREAN MED SCI, V22, P546-
dc.description.citedreferenceSong HJ, 2007, J KOREAN MED SCI, V22, P218-
dc.description.citedreferenceRein DB, 2007, PEDIATRICS, V119, pE12, DOI 10.1542/peds.2006-1573-
dc.description.citedreferenceSONG YB, 2007, KOREAN J HEPATOL, V13, P27-
dc.description.citedreferenceValenzuela MT, 2005, VACCINE, V23, P4110, DOI 10.1016/j.vaccine.2005.03.021-
dc.description.citedreferenceDagan R, 2005, JAMA-J AM MED ASSOC, V294, P202-
dc.description.citedreferenceJacobsen KH, 2005, INT J EPIDEMIOL, V34, P600, DOI 10.1093/ije/dyi062-
dc.description.citedreferenceFiore AE, 2004, CLIN INFECT DIS, V38, P705, DOI 10.1086/381671-
dc.description.citedreferenceJenson HB, 2004, CURR OPIN PEDIATR, V16, P89-
dc.description.citedreferenceSOHN YM, 2004, PUBLIC HLTH, V35, P954-
dc.description.citedreferenceWang SM, 2001, J MED VIROL, V64, P104-
dc.description.citedreferenceSaab S, 2000, AM J MED, V109, P241, DOI 10.1016/S0002-9343(00)00469-1-
dc.description.citedreferenceTanaka J, 2000, VACCINE, V18, pS57-
dc.description.citedreferenceTufenkeji H, 2000, VACCINE, V18, pS65-
dc.description.citedreferenceSohn YM, 2000, YONSEI MED J, V41, P34-
dc.description.citedreferenceBARZAGA BN, 2000, VACCINE S1, V18, pS61-
dc.description.citedreferenceLee A, 1999, PUBLIC HEALTH, V113, P185-
dc.description.citedreferenceBuma AH, 1998, MIL MED, V163, P564-
dc.description.citedreferenceSchwartz E, 1998, INT J EPIDEMIOL, V27, P118-
dc.description.citedreferenceFenn P, 1998, J INFECTION, V36, P17-
dc.description.citedreferenceSmith S, 1997, INFECT CONT HOSP EP, V18, P688-
dc.description.citedreferenceAMELA C, 1995, EUR J EPIDEMIOL, V11, P569-
dc.description.citedreferenceSHAPIRO CN, 1993, J HEPATOL, V18, pS11-
dc.description.citedreferenceROBERTSON BH, 1992, J GEN VIROL, V73, P1365-
dc.description.citedreferenceGUST ID, 1992, VACCINE, V10, pS56-
dc.description.citedreferenceKOFF RS, 1992, VACCINE, V10, pS15-
dc.description.citedreferenceXU ZY, 1992, VACCINE, V10, pS67-
dc.description.citedreferenceKREMASTINOU J, 1984, AM J EPIDEMIOL, V120, P703-
dc.description.citedreferenceSIEGL G, 1981, J GEN VIROL, V57, P331-
dc.description.citedreferenceHADLER SC, 1980, NEW ENGL J MED, V302, P1222-
dc.description.citedreferenceFEINSTON.SM, 1973, SCIENCE, V182, P1026-
dc.description.tc7-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share